CORC  > 湖南中医药大学
A novel recombinant peptide INSR-IgG4Fc (Yiminsu) restores insulin sensitivity in experimental insulin resistance models
Wang, Jing; Shi, Zhe; Zou, Tao; Zou, Min-Xu; Yang, Hui-Xian; Zhang, Cai-Ping; Xiang, De-Biao; Lin, Li-Mei; Liu, Hui-Yu*; Fang, De-yu*
刊名Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
2019
卷号109页码:1276-1286
关键词Insulin resistance PI3K-Akt pathway Recombinant peptide Type 2 diabetes mellitus Yiminsu
ISSN号0753-3322
DOI10.1016/j.biopha.2018.10.074
URL标识查看原文
WOS记录号WOS:000452539100139
内容类型期刊论文
URI标识http://www.corc.org.cn/handle/1471x/5708203
专题湖南中医药大学
作者单位1.[Yang, Hui-Xian
2.Wang, Jing
3.Liu, Hui-Yu] Univ South China, Sch Publ Hlth, Hengyang, Hunan, Peoples R China.
推荐引用方式
GB/T 7714
Wang, Jing,Shi, Zhe,Zou, Tao,et al. A novel recombinant peptide INSR-IgG4Fc (Yiminsu) restores insulin sensitivity in experimental insulin resistance models[J]. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie,2019,109:1276-1286.
APA Wang, Jing.,Shi, Zhe.,Zou, Tao.,Zou, Min-Xu.,Yang, Hui-Xian.,...&Liao, Duan-Fang*.(2019).A novel recombinant peptide INSR-IgG4Fc (Yiminsu) restores insulin sensitivity in experimental insulin resistance models.Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie,109,1276-1286.
MLA Wang, Jing,et al."A novel recombinant peptide INSR-IgG4Fc (Yiminsu) restores insulin sensitivity in experimental insulin resistance models".Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 109(2019):1276-1286.
个性服务
查看访问统计
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。


©版权所有 ©2017 CSpace - Powered by CSpace